Search for Clinical Trial Results

Sponsored By

Pancreatic Neuroendocrine Tumor - 25 Studies Found

Status Study
Active, not recruiting Study Name: Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors
Condition:
  • Neuroendocrine Tumors
  • Gastro Entero Pancreatic Neuroendocrine Tumors Date: 2016-04-07
    Interventions:
    • Drug: 28 GBq 177Lu-DOTATATE Pa
Completed Study Name: Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors
Condition:
  • Advanced Renal Cell Carcinoma
  • Gastrointestinal Stromal Tumors
  • Neuroendocrine Tumor
  • Carcinoid Tumor
  • Date: 2009-12-01
    Interventions: Drug: AMG 479 Given intravenously once every three weeks
Completed Study Name: Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver
Condition: Pancreatic Neuroendocrine Tumor
Date: 2025-11-05
Interventions: Cytoreductive surgery is an operation to remove as much tumor tissue as possible.
COMPLETED Study Name: A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly
Condition: Gastro-enteropancreatic Neuroendocrine Tumor
Date: 2025-11-05
<<< Previous